{"transactions":[{"id":1437923,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":88434,"kind":"person","name":"Habig Scott Michael","position":1,"cik":"0001938159","reported_name":"Habig Scott Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-08T16:06:59.000Z","date":"2024-08-06","kind":"sale","planned":false,"acquired":false,"shares":18249,"price":5.31,"value":96902.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the August 1, 2022 grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.29 to $5.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":456338,"source":{"system":"sec-edgar","filing":"0001600620-24-000093","document":"wk-form4_1723147608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938159/000160062024000093/wk-form4_1723147608.xml","form_type":"4"}},{"id":1589424,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":88434,"kind":"person","name":"Habig Scott Michael","position":1,"cik":"0001938159","reported_name":"Habig Scott Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T16:42:46.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":17777,"price":5.6,"value":99551.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 2, 2023 grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.475 to $5.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":474587,"source":{"system":"sec-edgar","filing":"0001600620-24-000035","document":"wk-form4_1709847750.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938159/000160062024000035/wk-form4_1709847750.xml","form_type":"4"}},{"id":1625785,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":88434,"kind":"person","name":"Habig Scott Michael","position":1,"cik":"0001938159","reported_name":"Habig Scott Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T16:33:06.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":15867,"price":5.48,"value":86951.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant."}],"balance_after":492364,"source":{"system":"sec-edgar","filing":"0001600620-24-000021","document":"wk-form4_1708637563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1938159/000160062024000021/wk-form4_1708637563.xml","form_type":"4"}},{"id":1625784,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":88434,"kind":"person","name":"Habig Scott Michael","position":1,"cik":"0001938159","reported_name":"Habig Scott Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T16:33:06.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":195512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date."}],"balance_after":508231,"source":{"system":"sec-edgar","filing":"0001600620-24-000021","document":"wk-form4_1708637563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938159/000160062024000021/wk-form4_1708637563.xml","form_type":"4"}},{"id":1969534,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":88434,"kind":"person","name":"Habig Scott Michael","position":1,"cik":"0001938159","reported_name":"Habig Scott Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-06T16:28:35.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":170188,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 170,188 newly awarded RSUs and 137,531 RSUs previously reported in Table II, which vests in three (3) equal annual installments beginning August 1, 2023 and 5,000 shares of common stock."}],"balance_after":312719,"source":{"system":"sec-edgar","filing":"0001628280-23-006528","document":"wf-form4_167813810165437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938159/000162828023006528/wf-form4_167813810165437.xml","form_type":"4"}},{"id":2118330,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":88434,"kind":"person","name":"Habig Scott Michael","position":1,"cik":"0001938159","reported_name":"Habig Scott Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-11-14T16:31:50.000Z","date":"2022-11-09","kind":"purchase","acquired":true,"shares":5000,"price":5.015,"value":25075.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001628280-22-029866","document":"wf-form4_166846148591533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938159/000162828022029866/wf-form4_166846148591533.xml","form_type":"4"}},{"id":2199199,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":88434,"kind":"person","name":"Habig Scott Michael","position":1,"cik":"0001938159","reported_name":"Habig Scott Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-01T16:13:22.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":137531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning August 1, 2023."}],"balance_after":137531,"derivative":{"underlying":"Common Shares","underlying_shares":137531},"source":{"system":"sec-edgar","filing":"0001628280-22-019949","document":"wf-form4_165938478001230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1938159/000162828022019949/wf-form4_165938478001230.xml","form_type":"4"}},{"id":2199198,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":88434,"kind":"person","name":"Habig Scott Michael","position":1,"cik":"0001938159","reported_name":"Habig Scott Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-01T16:13:22.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":231203,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":231203,"derivative":{"exercise_price":8.18,"expiration_date":"2032-08-01","underlying":"Common Stock","underlying_shares":231203},"source":{"system":"sec-edgar","filing":"0001628280-22-019949","document":"wf-form4_165938478001230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938159/000162828022019949/wf-form4_165938478001230.xml","form_type":"4"}}]}